China Resources Medical Holdings Company Limited (HKG:1515)
Hong Kong
· Delayed Price · Currency is HKD 3.810
-0.020 (-0.52%)
Apr 3, 2025, 11:44 AM HKT
HKG:1515 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | - | 257.68 | 265.86 | 417.92 | 310.13 | Upgrade
|
| Depreciation & Amortization | - | 610.86 | 486.41 | 182.88 | 113.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 2.39 | -5.41 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 351.81 | 108.83 | 11.15 | 3.59 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 145.87 | 22.18 | 371.56 | 45.08 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -90.78 | -88.07 | -83.55 | -34.97 | Upgrade
|
| Stock-Based Compensation | - | - | 2.16 | 10.11 | 8.72 | Upgrade
|
| Other Operating Activities | - | 230.61 | 159.42 | -348.79 | -101.65 | Upgrade
|
| Change in Accounts Receivable | - | -111.25 | 109.17 | 131.47 | 81.1 | Upgrade
|
| Change in Inventory | - | 65.18 | -17.34 | 0.21 | -23.29 | Upgrade
|
| Change in Accounts Payable | - | 9.71 | -152.76 | -31.99 | 82.01 | Upgrade
|
| Change in Unearned Revenue | - | 17.21 | 8.54 | -0.09 | - | Upgrade
|
| Change in Other Net Operating Assets | - | -294.17 | -35.4 | 49.56 | 159.59 | Upgrade
|
| Operating Cash Flow | - | 1,195 | 863.59 | 710.43 | 643.69 | Upgrade
|
| Operating Cash Flow Growth | - | 38.39% | 21.56% | 10.37% | 75.85% | Upgrade
|
| Capital Expenditures | - | -486.68 | -466.28 | -198.43 | -209.55 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 54.98 | 6.13 | 2.1 | 7.4 | Upgrade
|
| Cash Acquisitions | - | -3,768 | 173.92 | -669.61 | 49.52 | Upgrade
|
| Divestitures | - | - | 0.01 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -8 | Upgrade
|
| Investment in Securities | - | 872.18 | 381.34 | -1,096 | 160.8 | Upgrade
|
| Other Investing Activities | - | 705.46 | -589.13 | 26.26 | 60.19 | Upgrade
|
| Investing Cash Flow | - | -2,622 | -494.02 | -1,936 | 60.37 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 455.24 | Upgrade
|
| Long-Term Debt Issued | - | 5,554 | 8,614 | 6,073 | - | Upgrade
|
| Total Debt Issued | - | 5,554 | 8,614 | 6,073 | 455.24 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.26 | -1.56 | -315.44 | Upgrade
|
| Long-Term Debt Repaid | - | -5,819 | -8,650 | -5,106 | -8.68 | Upgrade
|
| Total Debt Repaid | - | -5,819 | -8,651 | -5,107 | -324.12 | Upgrade
|
| Net Debt Issued (Repaid) | - | -265.28 | -36.68 | 965.15 | 131.12 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.54 | 0.98 | Upgrade
|
| Common Dividends Paid | - | -42.35 | -129.6 | -91.08 | -115.09 | Upgrade
|
| Other Financing Activities | - | -129.45 | -57.41 | -28.66 | -24.38 | Upgrade
|
| Financing Cash Flow | - | -437.08 | -223.69 | 845.96 | -7.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.14 | 2.73 | 2.34 | -1.52 | Upgrade
|
| Net Cash Flow | - | -1,864 | 148.61 | -377.32 | 695.15 | Upgrade
|
| Free Cash Flow | - | 708.44 | 397.31 | 512 | 434.14 | Upgrade
|
| Free Cash Flow Growth | - | 78.31% | -22.40% | 17.93% | 31.68% | Upgrade
|
| Free Cash Flow Margin | - | 7.01% | 5.03% | 11.51% | 15.78% | Upgrade
|
| Free Cash Flow Per Share | - | 0.56 | 0.32 | 0.41 | 0.34 | Upgrade
|
| Cash Interest Paid | - | 116.27 | 56.4 | 19.77 | 14.22 | Upgrade
|
| Cash Income Tax Paid | - | 163.4 | 143.84 | 135.99 | 98.27 | Upgrade
|
| Levered Free Cash Flow | - | 1,843 | 235.59 | 569.68 | 555.25 | Upgrade
|
| Unlevered Free Cash Flow | - | 1,915 | 270.53 | 579.83 | 565.89 | Upgrade
|
| Change in Net Working Capital | 207.57 | -1,258 | 32.76 | -355.47 | -487.52 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.